← back to search

Min-Su Kang

Gyeongsang National University · KR
Area of research
Food Science · Surgery
Research interest
Research interests include Salmonella and Campylobacter epidemiology, Cholangiocarcinoma and Gallbladder Cancer Studies, Viral gastroenteritis research and epidemiology, and Gallbladder and Bile Duct Disorders.
h-index
22
citations
1,762
works
141
NIH funding
primary concept
email

Recent publications

A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The <scp>MAGIC</scp> ‐D Index
Liver International 2025cited by 6position: middledoi
Factors associated with reaching maintenance therapy in patients with advanced biliary tract cancer treated with durvalumab: Real‐world results from a multicenter and multinational study
International Journal of Cancer 2025cited by 2position: middledoi
The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population
JNCI Journal of the National Cancer Institute 2025cited by 2position: middledoi
Negative impact of corticosteroid use on outcome in patients with advanced <scp>BTCs</scp> treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population
International Journal of Cancer 2025cited by 1position: middledoi
Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab
European Journal of Cancer 2025cited by 0position: middledoi
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population
European Journal of Cancer 2024cited by 42position: middledoi
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population
The Oncologist 2024cited by 7position: middledoi
Durvalumab Plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer: A Large Real-Life Worldwide Population
SSRN Electronic Journal 2024cited by 3position: middledoi
Impact of Antibiotic Therapy in Patients with Cholangiocarcinoma Treated with Chemoimmunotherapy
SSRN Electronic Journal 2024cited by 0position: middledoi
Longitudinal evaluation of aflatoxin exposure in two cohorts in south-western Uganda
Food Additives & Contaminants Part A 2015cited by 37position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2015–2015)David Serwadda · National Institute of Allergy and Infectious Diseases1 papers (2015–2015)Guoqing Qian · Ningbo University Affiliated Hospital1 papers (2015–2015)Xiao Song · University of Georgia1 papers (2015–2015)Robert Newton · London School of Hygiene & Tropical Medicine1 papers (2015–2015)John C. Ssempebwa · University of Georgia1 papers (2015–2015) · 1 papers (2015–2015)Janet Seeley · London School of Hygiene & Tropical Medicine1 papers (2015–2015)Fred Nalugoda · Case Western Reserve University1 papers (2015–2015)Jia-Sheng Wang · Kunming University of Science and Technology1 papers (2015–2015)Tom Lutalo · London School of Hygiene & Tropical Medicine1 papers (2015–2015)Lili Tang · University of Georgia1 papers (2015–2015)Pontiano Kaleebu · Uganda Virus Research Institute1 papers (2015–2015)Jonathan H. William · University of Georgia1 papers (2015–2015)Kathy S. Xue · University of Georgia1 papers (2015–2015)Allan Nkwata · University of Georgia1 papers (2015–2015)